About Us
POUND INTERNATIONAL ltd IS THE MARKETING AUTHORISATION HOLDER OF
STUD 100
Established in 1958, Pound International Ltd is a UK registered company located in Oxfordshire. We are the Marketing Authorisation Holder for STUD 100® Desensitizing Spray for Men.
Pound International oversees the manufacture and sale of STUD 100 to licensed pharmacists, wholesalers and registered distributors around the world.
We are proud members of the London Chamber of Commerce.
STUD 100 is a licensed medicinal product and like all medicinal products, is regulated by the Medicines & Healthcare products Regulatory Agency (MHRA).
All our processes have been designed with Good Distribution Practice (GDP) embedded.
Pound International Ltd operate a defined quality management
system to assure the quality of our product - STUD 100.
The product is made by a licensed manufacturer and is distributed via quality managed processes to the highest safety standards to meet the requirements of customers and the regulatory authorities.
We have global reach with appointed distributors in different territories around the world.
Our Aims - We look to develop enduring partnerships with customers, and always offer great customer service in line with industry best practices.
ABOUT THE PRODUCT - STUD 100
STUD 100® Desensitizing Spray for Men has been licensed in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA) since 1972. (when medicinal legislation was introduced) and is a topical spray containing lidocaine.
It is a pharmaceutical over the counter product, which means you do not need a prescription to obtain it.
You can purchase it from a reputable Pharmacy in store or online.
STUD 100 is also licensed as a medicinal product in other countries around the world and may be subject to different regulatory requirements depending on the country. STUD 100 is packaged in different formats worldwide in order to meet each territory’s requirements e.g. it is supplied to an authorised Distributor in the USA with a black child-resistant cap in order to meet the requirements of the FDA Monograph on Male Genital Desensitizers.